Skip to content
MATR
  • Home
  • Events
  • Jobs
  • Sponsors
  • Supporters
  • About Us
    • Our Mission
    • Become A MATR Sponsor
    • Contact
    • Newsletter Archives
The state with the best education wins!
  • Register/Sign Up
  • Log In
MATR
  • Home
  • Events
  • Jobs
  • Sponsors
  • Supporters
  • About Us
    • Our Mission
    • Become A MATR Sponsor
    • Contact
    • Newsletter Archives

News

First sleep apnea drug reduces severity in 70% of trial cases

March 18, 2024/No Comments

“Those who had a physiological improvement in their airway function during sleep also had between 25–45% reductions in markers of their OSA severity, including improved oxygen levels as well as a reduction in their blood pressure the next day.”

By Paul McClure


Click here to read the story.

Related Stories

  1. Wearable treats pain and depression in as little as one 40-minute session
  2. Fitbit data accurately predicts bipolar disorder mood swings

Leave a Comment Cancel Reply

You must be logged in to post a comment.

MATR Sponsor (view all)


"For small to medium to national organizations, for events and fundraisers of any size, in any format – live, virtual or hybrid – the platform is built for scale."

MATR Supporters (view all)


The Great Falls Development Alliance delivers aggressive, award-winning economic development support for business attraction, expansion, and retention.

Make Your Future in the College of Business

Prospera's mission is to advance and inspire diverse economies and communities in southwest Montana.

© 2026 MATR. All Rights Reserved.

Proudly Powered and Sponsored by:

Privacy Policy

15585

The best in Montana tech news

Get the most useful news and opportunities in tech twice a week, all for free.

15856